Published May 1996 | Version v1
Journal article

Evaluation of livertaxis of antiviral drug NGA-ACV and its mechanism

  • 1. West China Univ. of Medical Sciences, Chengdu (China)

Description

Livertaxis of antiviral drug galactosyl-neoglycoalbumin-(NGA)-acyclovir(ACV) and its mechanism are assessed by using radioactive tracer technique. NGA was a synthetic ligand specific for asialoglycoprotein receptor, which existed in the mammalian liver only. NGA as a carrier of hepatic targeting drugs was coupled with an antiviral drugs ACV via a butanediamide bridge to form a conjugator NGA-ACV. NGA-ACV was labelled with 131I. The data of distribution in mice, animal (rabbit and chicken) and HPLC assay were obtained. NGA-ACV had remarkable livertaxis and its uptake in liver was over 80% with the feature of receptor-mediated binding to hepatocytes in vivo. NGA-ACV is a potential receptor-mediated hepatic targeting antiviral drug

Additional details

Publishing Information

Journal Title
Chinese Journal of Nuclear Medicine
Journal Volume
16
Journal Issue
2
Journal Page Range
p. 116-118.
ISSN
0253-9780
CODEN
CITCDE